CapEx / revenue
Cash purchases of property, plant and equipment divided by revenue.
How it is calculated
Calculated as capex / revenue, from Capital expenditures, Revenue. A figure the company reported directly always outranks this calculation, and it is withheld when its inputs come from different filing vintages.
Highest reported
| Company | CapEx / revenue | Period end |
|---|---|---|
| ACHR Archer Aviation Inc. | 26266.7% | 2025-12-31 |
| GNLX GENELUX Corp | 13725.0% | 2025-12-31 |
| SPCE Virgin Galactic Holdings, Inc | 12826.7% | 2025-12-31 |
| ATLX Atlas Lithium Corp | 6586.1% | 2025-12-31 |
| LYEL Lyell Immunopharma, Inc. | 2166.7% | 2025-12-31 |
| INMB Inmune Bio, Inc. | 2084.0% | 2025-12-31 |
| TCRT Alaunos Therapeutics, Inc. | 1960.0% | 2025-12-31 |
| PROK PROKIDNEY CORP. | 1701.7% | 2025-12-31 |
| ASTS AST SpaceMobile, Inc. | 1501.4% | 2025-12-31 |
| FFAI FARADAY FUTURE INTELLIGENT ELECTRIC INC. | 1426.1% | 2025-12-31 |
| SERV Serve Robotics Inc. /DE/ | 1408.3% | 2025-12-31 |
| BINI BOLLINGER INNOVATIONS, INC. | 1347.7% | 2024-09-30 |
| CDIO Cardio Diagnostics Holdings, Inc. | 1263.5% | 2025-12-31 |
| NVNO enVVeno Medical Corp | 1164.7% | 2019-12-31 |
| CADL Candel Therapeutics, Inc. | 1037.6% | 2022-12-31 |
Latest annual period for each company; fiscal year ends differ. Figures are the filers’ own.
Every figure on this site links to the filing it came from. See the methodology for how periods and concepts are chosen, and the disclosures for what the data is not.